Gemina Laboratories Statistics

Total Valuation

Gemina Laboratories has a market cap or net worth of CAD 40.27 million. The enterprise value is 41.69 million.

Market Cap	40.27M
Enterprise Value	41.69M

Important Dates

The next estimated earnings date is Friday, May 30, 2025.

Earnings Date	May 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Gemina Laboratories has 74.57 million shares outstanding. The number of shares has increased by 6.20% in one year.

Current Share Class	n/a
Shares Outstanding	74.57M
Shares Change (YoY)	+6.20%
Shares Change (QoQ)	+1.31%
Owned by Insiders (%)	1.00%
Owned by Institutions (%)	n/a
Float	37.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-12.21
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-33.60

Financial Position

The company has a current ratio of 0.03

Current Ratio	0.03
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	-1.17
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-138.31%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	109.03%
Revenue Per Employee	n/a
Profits Per Employee	-569,083
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -3.57% in the last 52 weeks. The beta is 0.84, so Gemina Laboratories's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-3.57%
50-Day Moving Average	0.67
200-Day Moving Average	0.50
Relative Strength Index (RSI)	40.80
Average Volume (20 Days)	9,883

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.55M
Pretax Income	-3.41M
Net Income	-3.41M
EBITDA	-3.52M
EBIT	-3.55M
Earnings Per Share (EPS)	-0.05

Full Income Statement

Balance Sheet

The company has 41,612 in cash and 1.46 million in debt, giving a net cash position of -1.42 million or -0.02 per share.

Cash & Cash Equivalents	41,612
Total Debt	1.46M
Net Cash	-1.42M
Net Cash Per Share	-0.02
Equity (Book Value)	-3.46M
Book Value Per Share	-0.05
Working Capital	-4.62M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -1.26 million and capital expenditures 16,258, giving a free cash flow of -1.24 million.

Operating Cash Flow	-1.26M
Capital Expenditures	16,258
Free Cash Flow	-1.24M
FCF Per Share	-0.02

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Gemina Laboratories does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.20%
Shareholder Yield	-6.20%
Earnings Yield	-8.48%
FCF Yield	-3.08%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a